Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma

Table 2 Response rates according to modified Response Evaluation Criteria in Solid Tumors criteria, n (%)

Response	Treatment group			P value
	Overall cohort	TACE/HAIC + S-1, n = 55	TACE/HAIC, n = 60
CR	8	4 (7.3)	4 (6.7)	1.000
PR	20	13 (23.6)	7 (11.7)	0.148
SD	46	23 (41.8)	23 (38.3)	0.849
PD	41	15 (27.3)	26 (43.3)	0.109
ORR	28	17 (30.9)	11 (18.3)	0.176
DCR	74	40 (72.7)	34 (56.7)	0.109

CR: Complete response; DCR: Disease control rate; HAIC: Hepatic arterial infusion chemotherapy; ORR: Objective response rate; PD: Progressive disease; PR: Partial response; SD: Stable disease; TACE: Transarterial chemoembolization.